These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 29565400)
1. Partners in discovery. Fuyuno I Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400 [No Abstract] [Full Text] [Related]
2. Lost opportunities. Phan P; Wong D Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004 [No Abstract] [Full Text] [Related]
3. An audience with...Francis Collins. Interviewed by Asher Mullard. Collins F Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031 [No Abstract] [Full Text] [Related]
4. Leveraging public private partnerships to innovate under challenging budget times. Portilla LM; Rohrbaugh ML Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971 [TBL] [Abstract][Full Text] [Related]
6. Academia-pharma partnerships for novel drug discovery: essential or nice to have? Palmer M; Chaguturu R Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189 [No Abstract] [Full Text] [Related]
7. How to help the free market fight coronavirus. Burley SK Nature; 2020 Apr; 580(7802):167. PubMed ID: 32210376 [No Abstract] [Full Text] [Related]
9. Competition: Unlikely partnerships. Savage N Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391 [No Abstract] [Full Text] [Related]
10. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
11. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare. Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665 [TBL] [Abstract][Full Text] [Related]
12. Drug discovery: new models for industry-academic partnerships. Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364 [TBL] [Abstract][Full Text] [Related]
13. The innovative medicines initiative: a European response to the innovation challenge. Goldman M Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619 [TBL] [Abstract][Full Text] [Related]
14. Managing intellectual property to develop medicines for the world's poorest. Fonteilles-Drabek S; Reddy D; Wells TN Nat Rev Drug Discov; 2017 Apr; 16(4):223-224. PubMed ID: 28232725 [TBL] [Abstract][Full Text] [Related]
16. Drug development: Time for teamwork. May M Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427 [No Abstract] [Full Text] [Related]
17. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges. Ioset JR; Chang S Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842 [TBL] [Abstract][Full Text] [Related]
18. [Cohorts and registers: Which public/private partnerships to choose?]. Jouan-Flahault C; Landais P; Thomas R; Parker S; Genevaz D Presse Med; 2012 May; 41 Suppl 1():S15-9. PubMed ID: 22464892 [No Abstract] [Full Text] [Related]
19. Pierre Meulien. Meulien P; Mullard A Nat Rev Drug Discov; 2015 Aug; 14(8):521. PubMed ID: 26228752 [No Abstract] [Full Text] [Related]
20. Open PHACTS: semantic interoperability for drug discovery. Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]